nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Clomipramine—HRH2—coronary artery disease	0.00158	0.126	CrCbGaD
Propericiazine—Nausea—Gemfibrozil—coronary artery disease	0.000715	0.00109	CcSEcCtD
Propericiazine—Body temperature increased—Clopidogrel—coronary artery disease	0.000713	0.00109	CcSEcCtD
Propericiazine—Insomnia—Olmesartan—coronary artery disease	0.000713	0.00108	CcSEcCtD
Propericiazine—Hyperhidrosis—Trandolapril—coronary artery disease	0.000712	0.00108	CcSEcCtD
Propericiazine—Confusional state—Captopril—coronary artery disease	0.000709	0.00108	CcSEcCtD
Propericiazine—Hyperhidrosis—Enalapril—coronary artery disease	0.000709	0.00108	CcSEcCtD
Propericiazine—Body temperature increased—Lovastatin—coronary artery disease	0.000709	0.00108	CcSEcCtD
Propericiazine—Dyspnoea—Valsartan—coronary artery disease	0.000706	0.00107	CcSEcCtD
Propericiazine—Tachycardia—Telmisartan—coronary artery disease	0.000706	0.00107	CcSEcCtD
Propericiazine—Somnolence—Valsartan—coronary artery disease	0.000704	0.00107	CcSEcCtD
Propericiazine—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000703	0.00107	CcSEcCtD
Propericiazine—Cardiac disorder—Timolol—coronary artery disease	0.000701	0.00107	CcSEcCtD
Propericiazine—Hyperhidrosis—Telmisartan—coronary artery disease	0.000699	0.00106	CcSEcCtD
Propericiazine—Nausea—Ticagrelor—coronary artery disease	0.000698	0.00106	CcSEcCtD
Propericiazine—Dry mouth—Perindopril—coronary artery disease	0.000697	0.00106	CcSEcCtD
Propericiazine—Insomnia—Niacin—coronary artery disease	0.000696	0.00106	CcSEcCtD
Propericiazine—Body temperature increased—Ezetimibe—coronary artery disease	0.000695	0.00106	CcSEcCtD
Propericiazine—Arrhythmia—Ramipril—coronary artery disease	0.000691	0.00105	CcSEcCtD
Propericiazine—Confusional state—Perindopril—coronary artery disease	0.000688	0.00105	CcSEcCtD
Propericiazine—Hypotension—Trandolapril—coronary artery disease	0.000688	0.00105	CcSEcCtD
Propericiazine—Dyspnoea—Niacin—coronary artery disease	0.000686	0.00104	CcSEcCtD
Propericiazine—Tachycardia—Captopril—coronary artery disease	0.000686	0.00104	CcSEcCtD
Propericiazine—Insomnia—Pravastatin—coronary artery disease	0.000686	0.00104	CcSEcCtD
Propericiazine—Hypotension—Enalapril—coronary artery disease	0.000685	0.00104	CcSEcCtD
Propericiazine—Somnolence—Niacin—coronary artery disease	0.000684	0.00104	CcSEcCtD
Propericiazine—Oedema—Perindopril—coronary artery disease	0.000683	0.00104	CcSEcCtD
Propericiazine—Body temperature increased—Eplerenone—coronary artery disease	0.00068	0.00104	CcSEcCtD
Propericiazine—Dry mouth—Furosemide—coronary artery disease	0.000677	0.00103	CcSEcCtD
Propericiazine—Constipation—Valsartan—coronary artery disease	0.000677	0.00103	CcSEcCtD
Propericiazine—Hypersensitivity—Fenofibrate—coronary artery disease	0.000676	0.00103	CcSEcCtD
Propericiazine—Dyspnoea—Pravastatin—coronary artery disease	0.000676	0.00103	CcSEcCtD
Propericiazine—Hypotension—Telmisartan—coronary artery disease	0.000676	0.00103	CcSEcCtD
Propericiazine—Arrhythmia—Timolol—coronary artery disease	0.000675	0.00103	CcSEcCtD
Propericiazine—Constipation—Olmesartan—coronary artery disease	0.000674	0.00103	CcSEcCtD
Propericiazine—Confusional state—Furosemide—coronary artery disease	0.000669	0.00102	CcSEcCtD
Propericiazine—Rash—Rosuvastatin—coronary artery disease	0.000667	0.00101	CcSEcCtD
Propericiazine—Tachycardia—Perindopril—coronary artery disease	0.000666	0.00101	CcSEcCtD
Propericiazine—Dermatitis—Rosuvastatin—coronary artery disease	0.000666	0.00101	CcSEcCtD
Propericiazine—Insomnia—Trandolapril—coronary artery disease	0.000666	0.00101	CcSEcCtD
Propericiazine—Hypersensitivity—Clopidogrel—coronary artery disease	0.000665	0.00101	CcSEcCtD
Propericiazine—Insomnia—Enalapril—coronary artery disease	0.000663	0.00101	CcSEcCtD
Propericiazine—Body temperature increased—Simvastatin—coronary artery disease	0.000663	0.00101	CcSEcCtD
Propericiazine—Hypersensitivity—Lovastatin—coronary artery disease	0.00066	0.00101	CcSEcCtD
Propericiazine—Hyperhidrosis—Perindopril—coronary artery disease	0.00066	0.001	CcSEcCtD
Propericiazine—Clomipramine—GSTP1—coronary artery disease	0.000658	0.0523	CrCbGaD
Propericiazine—Hypotension—Captopril—coronary artery disease	0.000657	0.001	CcSEcCtD
Propericiazine—Dyspnoea—Trandolapril—coronary artery disease	0.000656	0.000999	CcSEcCtD
Propericiazine—Somnolence—Trandolapril—coronary artery disease	0.000654	0.000996	CcSEcCtD
Propericiazine—Insomnia—Telmisartan—coronary artery disease	0.000654	0.000995	CcSEcCtD
Propericiazine—Dyspnoea—Enalapril—coronary artery disease	0.000654	0.000995	CcSEcCtD
Propericiazine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000653	0.000994	CcSEcCtD
Propericiazine—Dry mouth—Losartan—coronary artery disease	0.000653	0.000994	CcSEcCtD
Propericiazine—Somnolence—Enalapril—coronary artery disease	0.000652	0.000992	CcSEcCtD
Propericiazine—Constipation—Pravastatin—coronary artery disease	0.000648	0.000986	CcSEcCtD
Propericiazine—Rash—Acetylsalicylic acid—coronary artery disease	0.000648	0.000986	CcSEcCtD
Propericiazine—Hypersensitivity—Ezetimibe—coronary artery disease	0.000648	0.000986	CcSEcCtD
Propericiazine—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000647	0.000985	CcSEcCtD
Propericiazine—Confusional state—Losartan—coronary artery disease	0.000646	0.000983	CcSEcCtD
Propericiazine—Dyspnoea—Telmisartan—coronary artery disease	0.000645	0.000981	CcSEcCtD
Propericiazine—Somnolence—Telmisartan—coronary artery disease	0.000643	0.000978	CcSEcCtD
Propericiazine—Hyperhidrosis—Furosemide—coronary artery disease	0.000642	0.000976	CcSEcCtD
Propericiazine—Oedema—Losartan—coronary artery disease	0.00064	0.000975	CcSEcCtD
Propericiazine—Hypotension—Perindopril—coronary artery disease	0.000638	0.000971	CcSEcCtD
Propericiazine—Infection—Losartan—coronary artery disease	0.000636	0.000968	CcSEcCtD
Propericiazine—Insomnia—Captopril—coronary artery disease	0.000636	0.000968	CcSEcCtD
Propericiazine—Tremor—Ramipril—coronary artery disease	0.00063	0.000959	CcSEcCtD
Propericiazine—Constipation—Trandolapril—coronary artery disease	0.00063	0.000958	CcSEcCtD
Propericiazine—Nausea—Rosuvastatin—coronary artery disease	0.000628	0.000956	CcSEcCtD
Propericiazine—Diarrhoea—Fenofibrate—coronary artery disease	0.000628	0.000956	CcSEcCtD
Propericiazine—Constipation—Enalapril—coronary artery disease	0.000627	0.000954	CcSEcCtD
Propericiazine—Dyspnoea—Captopril—coronary artery disease	0.000627	0.000954	CcSEcCtD
Propericiazine—Arrhythmia—Lisinopril—coronary artery disease	0.000626	0.000953	CcSEcCtD
Propericiazine—Somnolence—Captopril—coronary artery disease	0.000625	0.000951	CcSEcCtD
Propericiazine—Tachycardia—Losartan—coronary artery disease	0.000625	0.000951	CcSEcCtD
Propericiazine—Body temperature increased—Olmesartan—coronary artery disease	0.000623	0.000948	CcSEcCtD
Propericiazine—Hypotension—Furosemide—coronary artery disease	0.00062	0.000944	CcSEcCtD
Propericiazine—Vision blurred—Timolol—coronary artery disease	0.00062	0.000943	CcSEcCtD
Propericiazine—Hyperhidrosis—Losartan—coronary artery disease	0.000619	0.000942	CcSEcCtD
Propericiazine—Constipation—Telmisartan—coronary artery disease	0.000618	0.000941	CcSEcCtD
Propericiazine—Agitation—Ramipril—coronary artery disease	0.000618	0.000941	CcSEcCtD
Propericiazine—Hypersensitivity—Simvastatin—coronary artery disease	0.000618	0.00094	CcSEcCtD
Propericiazine—Insomnia—Perindopril—coronary artery disease	0.000618	0.00094	CcSEcCtD
Propericiazine—Diarrhoea—Clopidogrel—coronary artery disease	0.000617	0.00094	CcSEcCtD
Propericiazine—Angioedema—Ramipril—coronary artery disease	0.000615	0.000936	CcSEcCtD
Propericiazine—Diarrhoea—Lovastatin—coronary artery disease	0.000613	0.000933	CcSEcCtD
Propericiazine—Nausea—Acetylsalicylic acid—coronary artery disease	0.00061	0.000929	CcSEcCtD
Propericiazine—Dyspnoea—Perindopril—coronary artery disease	0.000609	0.000926	CcSEcCtD
Propericiazine—Body temperature increased—Niacin—coronary artery disease	0.000609	0.000926	CcSEcCtD
Propericiazine—Somnolence—Perindopril—coronary artery disease	0.000607	0.000924	CcSEcCtD
Propericiazine—Diarrhoea—Ezetimibe—coronary artery disease	0.000602	0.000915	CcSEcCtD
Propericiazine—Constipation—Captopril—coronary artery disease	0.000601	0.000915	CcSEcCtD
Propericiazine—Angioedema—Timolol—coronary artery disease	0.000601	0.000915	CcSEcCtD
Propericiazine—Body temperature increased—Pravastatin—coronary artery disease	0.000599	0.000912	CcSEcCtD
Propericiazine—Hypotension—Losartan—coronary artery disease	0.000598	0.000911	CcSEcCtD
Propericiazine—Somnolence—Furosemide—coronary artery disease	0.00059	0.000898	CcSEcCtD
Propericiazine—Diarrhoea—Eplerenone—coronary artery disease	0.000589	0.000896	CcSEcCtD
Propericiazine—Constipation—Perindopril—coronary artery disease	0.000584	0.000888	CcSEcCtD
Propericiazine—Vomiting—Fenofibrate—coronary artery disease	0.000584	0.000888	CcSEcCtD
Propericiazine—Hypersensitivity—Valsartan—coronary artery disease	0.000583	0.000888	CcSEcCtD
Propericiazine—Body temperature increased—Trandolapril—coronary artery disease	0.000582	0.000886	CcSEcCtD
Propericiazine—Body temperature increased—Enalapril—coronary artery disease	0.00058	0.000882	CcSEcCtD
Propericiazine—Insomnia—Losartan—coronary artery disease	0.000579	0.000881	CcSEcCtD
Propericiazine—Rash—Fenofibrate—coronary artery disease	0.000579	0.000881	CcSEcCtD
Propericiazine—Dermatitis—Fenofibrate—coronary artery disease	0.000578	0.00088	CcSEcCtD
Propericiazine—Vision blurred—Lisinopril—coronary artery disease	0.000575	0.000875	CcSEcCtD
Propericiazine—Vomiting—Clopidogrel—coronary artery disease	0.000574	0.000873	CcSEcCtD
Propericiazine—Diarrhoea—Simvastatin—coronary artery disease	0.000574	0.000873	CcSEcCtD
Propericiazine—Tremor—Lisinopril—coronary artery disease	0.000572	0.00087	CcSEcCtD
Propericiazine—Body temperature increased—Telmisartan—coronary artery disease	0.000572	0.00087	CcSEcCtD
Propericiazine—Dyspnoea—Losartan—coronary artery disease	0.000571	0.000869	CcSEcCtD
Propericiazine—Vomiting—Lovastatin—coronary artery disease	0.00057	0.000867	CcSEcCtD
Propericiazine—Somnolence—Losartan—coronary artery disease	0.000569	0.000866	CcSEcCtD
Propericiazine—Rash—Clopidogrel—coronary artery disease	0.000569	0.000866	CcSEcCtD
Propericiazine—Dermatitis—Clopidogrel—coronary artery disease	0.000568	0.000865	CcSEcCtD
Propericiazine—Constipation—Furosemide—coronary artery disease	0.000568	0.000864	CcSEcCtD
Propericiazine—Hypersensitivity—Niacin—coronary artery disease	0.000567	0.000863	CcSEcCtD
Propericiazine—Rash—Lovastatin—coronary artery disease	0.000565	0.00086	CcSEcCtD
Propericiazine—Dermatitis—Lovastatin—coronary artery disease	0.000565	0.000859	CcSEcCtD
Propericiazine—Dry mouth—Ramipril—coronary artery disease	0.00056	0.000853	CcSEcCtD
Propericiazine—Vomiting—Ezetimibe—coronary artery disease	0.000559	0.000851	CcSEcCtD
Propericiazine—Hypersensitivity—Pravastatin—coronary artery disease	0.000559	0.00085	CcSEcCtD
Propericiazine—Angioedema—Lisinopril—coronary artery disease	0.000558	0.000848	CcSEcCtD
Propericiazine—Body temperature increased—Captopril—coronary artery disease	0.000556	0.000846	CcSEcCtD
Propericiazine—Cyamemazine—HTR2A—coronary artery disease	0.000555	0.0441	CrCbGaD
Propericiazine—Rash—Ezetimibe—coronary artery disease	0.000554	0.000844	CcSEcCtD
Propericiazine—Dermatitis—Ezetimibe—coronary artery disease	0.000554	0.000843	CcSEcCtD
Propericiazine—Confusional state—Ramipril—coronary artery disease	0.000554	0.000843	CcSEcCtD
Propericiazine—Oedema—Ramipril—coronary artery disease	0.000549	0.000836	CcSEcCtD
Propericiazine—Dry mouth—Timolol—coronary artery disease	0.000548	0.000833	CcSEcCtD
Propericiazine—Constipation—Losartan—coronary artery disease	0.000548	0.000833	CcSEcCtD
Propericiazine—Vomiting—Eplerenone—coronary artery disease	0.000547	0.000833	CcSEcCtD
Propericiazine—Nausea—Fenofibrate—coronary artery disease	0.000545	0.00083	CcSEcCtD
Propericiazine—Rash—Eplerenone—coronary artery disease	0.000543	0.000826	CcSEcCtD
Propericiazine—Hypersensitivity—Trandolapril—coronary artery disease	0.000542	0.000825	CcSEcCtD
Propericiazine—Dermatitis—Eplerenone—coronary artery disease	0.000542	0.000825	CcSEcCtD
Propericiazine—Diarrhoea—Valsartan—coronary artery disease	0.000542	0.000824	CcSEcCtD
Propericiazine—Confusional state—Timolol—coronary artery disease	0.000541	0.000824	CcSEcCtD
Propericiazine—Hypersensitivity—Enalapril—coronary artery disease	0.00054	0.000822	CcSEcCtD
Propericiazine—Body temperature increased—Perindopril—coronary artery disease	0.00054	0.000821	CcSEcCtD
Propericiazine—Diarrhoea—Olmesartan—coronary artery disease	0.000539	0.00082	CcSEcCtD
Propericiazine—Oedema—Timolol—coronary artery disease	0.000537	0.000817	CcSEcCtD
Propericiazine—Nausea—Clopidogrel—coronary artery disease	0.000536	0.000816	CcSEcCtD
Propericiazine—Tachycardia—Ramipril—coronary artery disease	0.000536	0.000816	CcSEcCtD
Propericiazine—Infection—Timolol—coronary artery disease	0.000533	0.000812	CcSEcCtD
Propericiazine—Vomiting—Simvastatin—coronary artery disease	0.000533	0.000811	CcSEcCtD
Propericiazine—Hypersensitivity—Telmisartan—coronary artery disease	0.000533	0.000811	CcSEcCtD
Propericiazine—Nausea—Lovastatin—coronary artery disease	0.000532	0.00081	CcSEcCtD
Propericiazine—Hyperhidrosis—Ramipril—coronary artery disease	0.000531	0.000808	CcSEcCtD
Propericiazine—Rash—Simvastatin—coronary artery disease	0.000529	0.000805	CcSEcCtD
Propericiazine—Dermatitis—Simvastatin—coronary artery disease	0.000528	0.000804	CcSEcCtD
Propericiazine—Diarrhoea—Niacin—coronary artery disease	0.000527	0.000802	CcSEcCtD
Propericiazine—Body temperature increased—Furosemide—coronary artery disease	0.000525	0.000798	CcSEcCtD
Propericiazine—Nausea—Ezetimibe—coronary artery disease	0.000522	0.000795	CcSEcCtD
Propericiazine—Hyperhidrosis—Timolol—coronary artery disease	0.000519	0.00079	CcSEcCtD
Propericiazine—Diarrhoea—Pravastatin—coronary artery disease	0.000519	0.000789	CcSEcCtD
Propericiazine—Hypotension—Ramipril—coronary artery disease	0.000513	0.000781	CcSEcCtD
Propericiazine—Nausea—Eplerenone—coronary artery disease	0.000511	0.000778	CcSEcCtD
Propericiazine—Dry mouth—Lisinopril—coronary artery disease	0.000508	0.000773	CcSEcCtD
Propericiazine—Thioridazine—HTR7—coronary artery disease	0.000508	0.0404	CrCbGaD
Propericiazine—Body temperature increased—Losartan—coronary artery disease	0.000506	0.00077	CcSEcCtD
Propericiazine—Diarrhoea—Trandolapril—coronary artery disease	0.000504	0.000766	CcSEcCtD
Propericiazine—Vomiting—Valsartan—coronary artery disease	0.000503	0.000766	CcSEcCtD
Propericiazine—Confusional state—Lisinopril—coronary artery disease	0.000502	0.000764	CcSEcCtD
Propericiazine—Diarrhoea—Enalapril—coronary artery disease	0.000502	0.000763	CcSEcCtD
Propericiazine—Hypotension—Timolol—coronary artery disease	0.000502	0.000763	CcSEcCtD
Propericiazine—Vomiting—Olmesartan—coronary artery disease	0.000501	0.000762	CcSEcCtD
Propericiazine—Rash—Valsartan—coronary artery disease	0.000499	0.00076	CcSEcCtD
Propericiazine—Dermatitis—Valsartan—coronary artery disease	0.000499	0.000759	CcSEcCtD
Propericiazine—Nausea—Simvastatin—coronary artery disease	0.000498	0.000758	CcSEcCtD
Propericiazine—Oedema—Lisinopril—coronary artery disease	0.000498	0.000758	CcSEcCtD
Propericiazine—Rash—Olmesartan—coronary artery disease	0.000497	0.000756	CcSEcCtD
Propericiazine—Insomnia—Ramipril—coronary artery disease	0.000497	0.000756	CcSEcCtD
Propericiazine—Dermatitis—Olmesartan—coronary artery disease	0.000496	0.000755	CcSEcCtD
Propericiazine—Diarrhoea—Telmisartan—coronary artery disease	0.000495	0.000753	CcSEcCtD
Propericiazine—Infection—Lisinopril—coronary artery disease	0.000495	0.000753	CcSEcCtD
Propericiazine—Dyspnoea—Ramipril—coronary artery disease	0.00049	0.000745	CcSEcCtD
Propericiazine—Vomiting—Niacin—coronary artery disease	0.00049	0.000745	CcSEcCtD
Propericiazine—Hypersensitivity—Furosemide—coronary artery disease	0.000489	0.000744	CcSEcCtD
Propericiazine—Somnolence—Ramipril—coronary artery disease	0.000488	0.000743	CcSEcCtD
Propericiazine—Tachycardia—Lisinopril—coronary artery disease	0.000486	0.00074	CcSEcCtD
Propericiazine—Insomnia—Timolol—coronary artery disease	0.000486	0.000739	CcSEcCtD
Propericiazine—Rash—Niacin—coronary artery disease	0.000485	0.000739	CcSEcCtD
Propericiazine—Dermatitis—Niacin—coronary artery disease	0.000485	0.000738	CcSEcCtD
Propericiazine—Vomiting—Pravastatin—coronary artery disease	0.000482	0.000733	CcSEcCtD
Propericiazine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000481	0.000733	CcSEcCtD
Propericiazine—Diarrhoea—Captopril—coronary artery disease	0.000481	0.000732	CcSEcCtD
Propericiazine—Dyspnoea—Timolol—coronary artery disease	0.000479	0.000728	CcSEcCtD
Propericiazine—Rash—Pravastatin—coronary artery disease	0.000478	0.000727	CcSEcCtD
Propericiazine—Dermatitis—Pravastatin—coronary artery disease	0.000478	0.000727	CcSEcCtD
Propericiazine—Somnolence—Timolol—coronary artery disease	0.000477	0.000726	CcSEcCtD
Propericiazine—Hypersensitivity—Losartan—coronary artery disease	0.000472	0.000718	CcSEcCtD
Propericiazine—Nausea—Valsartan—coronary artery disease	0.00047	0.000716	CcSEcCtD
Propericiazine—Constipation—Ramipril—coronary artery disease	0.00047	0.000715	CcSEcCtD
Propericiazine—Nausea—Olmesartan—coronary artery disease	0.000468	0.000712	CcSEcCtD
Propericiazine—Vomiting—Trandolapril—coronary artery disease	0.000468	0.000712	CcSEcCtD
Propericiazine—Diarrhoea—Perindopril—coronary artery disease	0.000467	0.000711	CcSEcCtD
Propericiazine—Vomiting—Enalapril—coronary artery disease	0.000466	0.000709	CcSEcCtD
Propericiazine—Perphenazine—HTR7—coronary artery disease	0.000466	0.037	CrCbGaD
Propericiazine—Hypotension—Lisinopril—coronary artery disease	0.000465	0.000708	CcSEcCtD
Propericiazine—Rash—Trandolapril—coronary artery disease	0.000464	0.000706	CcSEcCtD
Propericiazine—Dermatitis—Trandolapril—coronary artery disease	0.000464	0.000706	CcSEcCtD
Propericiazine—Rash—Enalapril—coronary artery disease	0.000462	0.000703	CcSEcCtD
Propericiazine—Dermatitis—Enalapril—coronary artery disease	0.000462	0.000703	CcSEcCtD
Propericiazine—Vomiting—Telmisartan—coronary artery disease	0.00046	0.0007	CcSEcCtD
Propericiazine—Nausea—Niacin—coronary artery disease	0.000457	0.000696	CcSEcCtD
Propericiazine—Quetiapine—HTR7—coronary artery disease	0.000457	0.0363	CrCbGaD
Propericiazine—Rash—Telmisartan—coronary artery disease	0.000456	0.000694	CcSEcCtD
Propericiazine—Dermatitis—Telmisartan—coronary artery disease	0.000456	0.000693	CcSEcCtD
Propericiazine—Diarrhoea—Furosemide—coronary artery disease	0.000454	0.000691	CcSEcCtD
Propericiazine—Insomnia—Lisinopril—coronary artery disease	0.00045	0.000685	CcSEcCtD
Propericiazine—Nausea—Pravastatin—coronary artery disease	0.00045	0.000685	CcSEcCtD
Propericiazine—Vomiting—Captopril—coronary artery disease	0.000447	0.00068	CcSEcCtD
Propericiazine—Dyspnoea—Lisinopril—coronary artery disease	0.000444	0.000676	CcSEcCtD
Propericiazine—Rash—Captopril—coronary artery disease	0.000443	0.000675	CcSEcCtD
Propericiazine—Dermatitis—Captopril—coronary artery disease	0.000443	0.000674	CcSEcCtD
Propericiazine—Somnolence—Lisinopril—coronary artery disease	0.000443	0.000674	CcSEcCtD
Propericiazine—Diarrhoea—Losartan—coronary artery disease	0.000438	0.000667	CcSEcCtD
Propericiazine—Nausea—Trandolapril—coronary artery disease	0.000437	0.000665	CcSEcCtD
Propericiazine—Nausea—Enalapril—coronary artery disease	0.000436	0.000663	CcSEcCtD
Propericiazine—Vomiting—Perindopril—coronary artery disease	0.000434	0.000661	CcSEcCtD
Propericiazine—Body temperature increased—Ramipril—coronary artery disease	0.000434	0.000661	CcSEcCtD
Propericiazine—Rash—Perindopril—coronary artery disease	0.000431	0.000655	CcSEcCtD
Propericiazine—Dermatitis—Perindopril—coronary artery disease	0.00043	0.000654	CcSEcCtD
Propericiazine—Nausea—Telmisartan—coronary artery disease	0.00043	0.000654	CcSEcCtD
Propericiazine—Constipation—Lisinopril—coronary artery disease	0.000426	0.000648	CcSEcCtD
Propericiazine—Body temperature increased—Timolol—coronary artery disease	0.000424	0.000646	CcSEcCtD
Propericiazine—Pipotiazine—CYP2C19—coronary artery disease	0.000423	0.0336	CrCbGaD
Propericiazine—Vomiting—Furosemide—coronary artery disease	0.000422	0.000642	CcSEcCtD
Propericiazine—Rash—Furosemide—coronary artery disease	0.000419	0.000637	CcSEcCtD
Propericiazine—Dermatitis—Furosemide—coronary artery disease	0.000418	0.000636	CcSEcCtD
Propericiazine—Nausea—Captopril—coronary artery disease	0.000418	0.000636	CcSEcCtD
Propericiazine—Vomiting—Losartan—coronary artery disease	0.000407	0.00062	CcSEcCtD
Propericiazine—Nausea—Perindopril—coronary artery disease	0.000406	0.000617	CcSEcCtD
Propericiazine—Hypersensitivity—Ramipril—coronary artery disease	0.000405	0.000616	CcSEcCtD
Propericiazine—Rash—Losartan—coronary artery disease	0.000404	0.000614	CcSEcCtD
Propericiazine—Dermatitis—Losartan—coronary artery disease	0.000403	0.000614	CcSEcCtD
Propericiazine—Zuclopenthixol—HTR2A—coronary artery disease	0.000398	0.0316	CrCbGaD
Propericiazine—Hypersensitivity—Timolol—coronary artery disease	0.000396	0.000602	CcSEcCtD
Propericiazine—Nausea—Furosemide—coronary artery disease	0.000394	0.0006	CcSEcCtD
Propericiazine—Body temperature increased—Lisinopril—coronary artery disease	0.000394	0.000599	CcSEcCtD
Propericiazine—Nausea—Losartan—coronary artery disease	0.00038	0.000579	CcSEcCtD
Propericiazine—Diarrhoea—Ramipril—coronary artery disease	0.000376	0.000572	CcSEcCtD
Propericiazine—Chlorpromazine—HTR7—coronary artery disease	0.00037	0.0294	CrCbGaD
Propericiazine—Diarrhoea—Timolol—coronary artery disease	0.000367	0.000559	CcSEcCtD
Propericiazine—Hypersensitivity—Lisinopril—coronary artery disease	0.000367	0.000558	CcSEcCtD
Propericiazine—Acepromazine—HTR2A—coronary artery disease	0.000356	0.0283	CrCbGaD
Propericiazine—Vomiting—Ramipril—coronary artery disease	0.000349	0.000531	CcSEcCtD
Propericiazine—Thioproperazine—HTR2A—coronary artery disease	0.000348	0.0277	CrCbGaD
Propericiazine—Rash—Ramipril—coronary artery disease	0.000346	0.000527	CcSEcCtD
Propericiazine—Dermatitis—Ramipril—coronary artery disease	0.000346	0.000526	CcSEcCtD
Propericiazine—Thiothixene—HTR2A—coronary artery disease	0.000343	0.0272	CrCbGaD
Propericiazine—Pipotiazine—HTR2A—coronary artery disease	0.000343	0.0272	CrCbGaD
Propericiazine—Vomiting—Timolol—coronary artery disease	0.000341	0.000519	CcSEcCtD
Propericiazine—Diarrhoea—Lisinopril—coronary artery disease	0.000341	0.000519	CcSEcCtD
Propericiazine—Rash—Timolol—coronary artery disease	0.000338	0.000515	CcSEcCtD
Propericiazine—Mesoridazine—HTR2A—coronary artery disease	0.000338	0.0269	CrCbGaD
Propericiazine—Dermatitis—Timolol—coronary artery disease	0.000338	0.000515	CcSEcCtD
Propericiazine—Clomipramine—CYP2C19—coronary artery disease	0.000334	0.0266	CrCbGaD
Propericiazine—Nausea—Ramipril—coronary artery disease	0.000326	0.000496	CcSEcCtD
Propericiazine—Nausea—Timolol—coronary artery disease	0.000319	0.000485	CcSEcCtD
Propericiazine—Vomiting—Lisinopril—coronary artery disease	0.000317	0.000482	CcSEcCtD
Propericiazine—Thioridazine—CYP2C19—coronary artery disease	0.000315	0.025	CrCbGaD
Propericiazine—Rash—Lisinopril—coronary artery disease	0.000314	0.000478	CcSEcCtD
Propericiazine—Dermatitis—Lisinopril—coronary artery disease	0.000314	0.000477	CcSEcCtD
Propericiazine—Fluphenazine—HTR2A—coronary artery disease	0.000296	0.0235	CrCbGaD
Propericiazine—Nausea—Lisinopril—coronary artery disease	0.000296	0.00045	CcSEcCtD
Propericiazine—Perphenazine—CYP2C19—coronary artery disease	0.000289	0.023	CrCbGaD
Propericiazine—Propiomazine—HTR2A—coronary artery disease	0.000285	0.0227	CrCbGaD
Propericiazine—Quetiapine—CYP2C19—coronary artery disease	0.000283	0.0225	CrCbGaD
Propericiazine—Clomipramine—HTR2A—coronary artery disease	0.000271	0.0215	CrCbGaD
Propericiazine—Promazine—CYP2C19—coronary artery disease	0.00026	0.0207	CrCbGaD
Propericiazine—Thioridazine—HTR2A—coronary artery disease	0.000255	0.0203	CrCbGaD
Propericiazine—Acepromazine—ALB—coronary artery disease	0.000244	0.0194	CrCbGaD
Propericiazine—Methotrimeprazine—HTR2A—coronary artery disease	0.000244	0.0194	CrCbGaD
Propericiazine—Promethazine—HTR2A—coronary artery disease	0.00024	0.0191	CrCbGaD
Propericiazine—Thioproperazine—ALB—coronary artery disease	0.000238	0.0189	CrCbGaD
Propericiazine—Trifluoperazine—HTR2A—coronary artery disease	0.000237	0.0188	CrCbGaD
Propericiazine—Thiothixene—ALB—coronary artery disease	0.000235	0.0186	CrCbGaD
Propericiazine—Pipotiazine—ALB—coronary artery disease	0.000235	0.0186	CrCbGaD
Propericiazine—Perphenazine—HTR2A—coronary artery disease	0.000234	0.0186	CrCbGaD
Propericiazine—Quetiapine—HTR2A—coronary artery disease	0.00023	0.0183	CrCbGaD
Propericiazine—Promazine—HTR2A—coronary artery disease	0.000211	0.0168	CrCbGaD
Propericiazine—Chlorpromazine—HTR2A—coronary artery disease	0.000186	0.0148	CrCbGaD
Propericiazine—Clomipramine—ALB—coronary artery disease	0.000185	0.0147	CrCbGaD
Propericiazine—Chlorpromazine—ALB—coronary artery disease	0.000127	0.0101	CrCbGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR2A—coronary artery disease	4.66e-05	0.000141	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EDN1—coronary artery disease	4.66e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—C3—coronary artery disease	4.66e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ABCA1—coronary artery disease	4.66e-05	0.000141	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDNRB—coronary artery disease	4.63e-05	0.00014	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL5—coronary artery disease	4.62e-05	0.00014	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—THBS1—coronary artery disease	4.56e-05	0.000138	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGF1—coronary artery disease	4.55e-05	0.000138	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CSF2—coronary artery disease	4.55e-05	0.000138	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ITGAV—coronary artery disease	4.54e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KNG1—coronary artery disease	4.53e-05	0.000137	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LPL—coronary artery disease	4.52e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—POMC—coronary artery disease	4.51e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CREB1—coronary artery disease	4.51e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PSMA6—coronary artery disease	4.51e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PSMB5—coronary artery disease	4.51e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GGT1—coronary artery disease	4.51e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GOT1—coronary artery disease	4.51e-05	0.000137	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—F2—coronary artery disease	4.5e-05	0.000136	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AGTR1—coronary artery disease	4.5e-05	0.000136	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MEF2C—coronary artery disease	4.48e-05	0.000136	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RPS6KB1—coronary artery disease	4.48e-05	0.000136	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AGT—coronary artery disease	4.42e-05	0.000134	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CCL2—coronary artery disease	4.41e-05	0.000134	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6R—coronary artery disease	4.4e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL10—coronary artery disease	4.4e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PLG—coronary artery disease	4.39e-05	0.000133	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDNRA—coronary artery disease	4.37e-05	0.000132	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ITGB3—coronary artery disease	4.37e-05	0.000132	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CYBA—coronary artery disease	4.35e-05	0.000132	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRB1—coronary artery disease	4.35e-05	0.000132	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—DUSP6—coronary artery disease	4.33e-05	0.000131	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRB2—coronary artery disease	4.27e-05	0.000129	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCL8—coronary artery disease	4.26e-05	0.000129	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLAT—coronary artery disease	4.26e-05	0.000129	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PPP2CA—coronary artery disease	4.24e-05	0.000128	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PRKCE—coronary artery disease	4.22e-05	0.000128	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—JAK2—coronary artery disease	4.21e-05	0.000128	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SOCS1—coronary artery disease	4.2e-05	0.000127	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—S100B—coronary artery disease	4.19e-05	0.000127	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PRKCD—coronary artery disease	4.16e-05	0.000126	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SOCS3—coronary artery disease	4.15e-05	0.000126	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—BDKRB2—coronary artery disease	4.11e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL12—coronary artery disease	4.11e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFBR2—coronary artery disease	4.1e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KITLG—coronary artery disease	4.1e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—POMC—coronary artery disease	4.1e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—F2—coronary artery disease	4.09e-05	0.000124	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—coronary artery disease	4.08e-05	0.000123	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR2A—coronary artery disease	4.08e-05	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6ST—coronary artery disease	4.07e-05	0.000123	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—C3—coronary artery disease	4.07e-05	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTP1—coronary artery disease	4.05e-05	0.000123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JUNB—coronary artery disease	4.03e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLCB1—coronary artery disease	4.02e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARGC1A—coronary artery disease	4.01e-05	0.000122	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—STAT5A—coronary artery disease	4.01e-05	0.000121	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP3—coronary artery disease	4.01e-05	0.000121	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HMOX1—coronary artery disease	3.99e-05	0.000121	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CAT—coronary artery disease	3.94e-05	0.000119	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR7—coronary artery disease	3.93e-05	0.000119	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HIF1A—coronary artery disease	3.88e-05	0.000118	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOB—coronary artery disease	3.88e-05	0.000117	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AGT—coronary artery disease	3.87e-05	0.000117	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCL8—coronary artery disease	3.84e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOB—coronary artery disease	3.83e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—JAK2—coronary artery disease	3.82e-05	0.000116	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EDN1—coronary artery disease	3.82e-05	0.000116	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LEP—coronary artery disease	3.79e-05	0.000115	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOE—coronary artery disease	3.79e-05	0.000115	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL5—coronary artery disease	3.79e-05	0.000115	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ITGAV—coronary artery disease	3.75e-05	0.000113	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—APOA1—coronary artery disease	3.75e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—coronary artery disease	3.74e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KNG1—coronary artery disease	3.74e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF1—coronary artery disease	3.73e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CSF2—coronary artery disease	3.73e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—POMC—coronary artery disease	3.72e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CREB1—coronary artery disease	3.72e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTM1—coronary artery disease	3.72e-05	0.000113	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGTR1—coronary artery disease	3.71e-05	0.000112	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KDR—coronary artery disease	3.71e-05	0.000112	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LPL—coronary artery disease	3.7e-05	0.000112	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK14—coronary artery disease	3.69e-05	0.000112	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—MAPK1—coronary artery disease	3.67e-05	0.000111	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MEF2C—coronary artery disease	3.67e-05	0.000111	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RPS6KB1—coronary artery disease	3.67e-05	0.000111	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—LPL—coronary artery disease	3.65e-05	0.000111	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CCL2—coronary artery disease	3.64e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6R—coronary artery disease	3.63e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL10—coronary artery disease	3.63e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PLG—coronary artery disease	3.62e-05	0.00011	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ESR1—coronary artery disease	3.62e-05	0.00011	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ITGB3—coronary artery disease	3.58e-05	0.000108	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—F2—coronary artery disease	3.57e-05	0.000108	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FN1—coronary artery disease	3.57e-05	0.000108	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GPX1—coronary artery disease	3.56e-05	0.000108	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6ST—coronary artery disease	3.56e-05	0.000108	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NFKBIA—coronary artery disease	3.53e-05	0.000107	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRB2—coronary artery disease	3.52e-05	0.000107	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL8—coronary artery disease	3.49e-05	0.000106	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCE—coronary artery disease	3.48e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—JAK2—coronary artery disease	3.48e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PPP2CA—coronary artery disease	3.47e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CD36—coronary artery disease	3.47e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SOCS1—coronary artery disease	3.47e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—S100B—coronary artery disease	3.46e-05	0.000105	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPP2CA—coronary artery disease	3.43e-05	0.000104	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SOCS3—coronary artery disease	3.43e-05	0.000104	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KIT—coronary artery disease	3.42e-05	0.000104	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PRKCD—coronary artery disease	3.41e-05	0.000103	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFBR2—coronary artery disease	3.39e-05	0.000103	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KITLG—coronary artery disease	3.39e-05	0.000103	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR2A—coronary artery disease	3.34e-05	0.000101	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—C3—coronary artery disease	3.33e-05	0.000101	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—STAT5A—coronary artery disease	3.31e-05	0.0001	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP3—coronary artery disease	3.31e-05	0.0001	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—coronary artery disease	3.29e-05	9.96e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—GSK3B—coronary artery disease	3.28e-05	9.94e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—POMC—coronary artery disease	3.25e-05	9.86e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CREB1—coronary artery disease	3.25e-05	9.86e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOB—coronary artery disease	3.2e-05	9.69e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCL2—coronary artery disease	3.18e-05	9.64e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PIK3CA—coronary artery disease	3.18e-05	9.64e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HIF1A—coronary artery disease	3.18e-05	9.62e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6R—coronary artery disease	3.18e-05	9.61e-05	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL8—coronary artery disease	3.17e-05	9.61e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AGT—coronary artery disease	3.17e-05	9.59e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—JAK2—coronary artery disease	3.16e-05	9.56e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDN1—coronary artery disease	3.15e-05	9.53e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IGF1—coronary artery disease	3.13e-05	9.48e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AGT—coronary artery disease	3.13e-05	9.46e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL5—coronary artery disease	3.12e-05	9.46e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—MAPK1—coronary artery disease	3.12e-05	9.43e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LEP—coronary artery disease	3.1e-05	9.4e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOE—coronary artery disease	3.1e-05	9.4e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CSF2—coronary artery disease	3.08e-05	9.32e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF1—coronary artery disease	3.08e-05	9.32e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—APOA1—coronary artery disease	3.07e-05	9.29e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOE—coronary artery disease	3.06e-05	9.27e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LPL—coronary artery disease	3.05e-05	9.25e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KDR—coronary artery disease	3.04e-05	9.2e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RPS6KB1—coronary artery disease	3.03e-05	9.17e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MEF2C—coronary artery disease	3.03e-05	9.17e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APOA1—coronary artery disease	3.03e-05	9.17e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK14—coronary artery disease	3.02e-05	9.14e-05	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PIK3CA—coronary artery disease	2.98e-05	9.02e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SERPINE1—coronary artery disease	2.97e-05	9e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ESR1—coronary artery disease	2.96e-05	8.97e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ITGB3—coronary artery disease	2.95e-05	8.93e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FN1—coronary artery disease	2.93e-05	8.86e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—F2—coronary artery disease	2.93e-05	8.86e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6ST—coronary artery disease	2.91e-05	8.82e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NFKBIA—coronary artery disease	2.89e-05	8.75e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL8—coronary artery disease	2.88e-05	8.72e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FGF2—coronary artery disease	2.88e-05	8.72e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PPP2CA—coronary artery disease	2.87e-05	8.68e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOS3—coronary artery disease	2.84e-05	8.59e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PRKCD—coronary artery disease	2.81e-05	8.52e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KIT—coronary artery disease	2.8e-05	8.48e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—JAK2—coronary artery disease	2.76e-05	8.35e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR2A—coronary artery disease	2.75e-05	8.34e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—C3—coronary artery disease	2.75e-05	8.33e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PIK3CA—coronary artery disease	2.7e-05	8.19e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—GSK3B—coronary artery disease	2.69e-05	8.14e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PPARG—coronary artery disease	2.67e-05	8.08e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—POMC—coronary artery disease	2.67e-05	8.07e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CREB1—coronary artery disease	2.67e-05	8.07e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—POMC—coronary artery disease	2.63e-05	7.97e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HIF1A—coronary artery disease	2.62e-05	7.94e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AGT—coronary artery disease	2.61e-05	7.91e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCL2—coronary artery disease	2.61e-05	7.9e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—AKT1—coronary artery disease	2.6e-05	7.88e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6R—coronary artery disease	2.6e-05	7.87e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IGF1—coronary artery disease	2.56e-05	7.76e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LEP—coronary artery disease	2.56e-05	7.75e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOE—coronary artery disease	2.56e-05	7.75e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—MAPK1—coronary artery disease	2.55e-05	7.73e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—APOA1—coronary artery disease	2.53e-05	7.67e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL8—coronary artery disease	2.52e-05	7.62e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KDR—coronary artery disease	2.51e-05	7.6e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK14—coronary artery disease	2.49e-05	7.55e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ESR1—coronary artery disease	2.44e-05	7.4e-05	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PIK3CA—coronary artery disease	2.44e-05	7.38e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SERPINE1—coronary artery disease	2.43e-05	7.37e-05	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—AKT1—coronary artery disease	2.43e-05	7.37e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—F2—coronary artery disease	2.41e-05	7.31e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FN1—coronary artery disease	2.41e-05	7.31e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CASP3—coronary artery disease	2.41e-05	7.3e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6ST—coronary artery disease	2.41e-05	7.28e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALB—coronary artery disease	2.4e-05	7.26e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—coronary artery disease	2.39e-05	7.25e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NFKBIA—coronary artery disease	2.39e-05	7.23e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FGF2—coronary artery disease	2.36e-05	7.14e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CCND1—coronary artery disease	2.35e-05	7.1e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOS3—coronary artery disease	2.32e-05	7.04e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KIT—coronary artery disease	2.31e-05	7e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NOS3—coronary artery disease	2.29e-05	6.95e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP9—coronary artery disease	2.28e-05	6.9e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—JAK2—coronary artery disease	2.26e-05	6.84e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—GSK3B—coronary artery disease	2.22e-05	6.72e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PIK3CA—coronary artery disease	2.21e-05	6.7e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—AKT1—coronary artery disease	2.21e-05	6.69e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—POMC—coronary artery disease	2.2e-05	6.66e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CREB1—coronary artery disease	2.2e-05	6.66e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCL2—coronary artery disease	2.15e-05	6.52e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6R—coronary artery disease	2.15e-05	6.5e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IGF1—coronary artery disease	2.12e-05	6.41e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—MAPK1—coronary artery disease	2.11e-05	6.38e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PTGS2—coronary artery disease	2.1e-05	6.35e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL8—coronary artery disease	2.06e-05	6.24e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—coronary artery disease	2.04e-05	6.19e-05	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PIK3CA—coronary artery disease	2.01e-05	6.09e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SERPINE1—coronary artery disease	2.01e-05	6.08e-05	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—AKT1—coronary artery disease	1.99e-05	6.03e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	1.97e-05	5.98e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	1.96e-05	5.94e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	1.95e-05	5.89e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	1.92e-05	5.82e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	1.92e-05	5.81e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—coronary artery disease	1.88e-05	5.68e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	1.86e-05	5.65e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	1.86e-05	5.65e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MAPK1—coronary artery disease	1.84e-05	5.57e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.83e-05	5.53e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	1.81e-05	5.48e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	1.7e-05	5.15e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	1.67e-05	5.07e-05	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	1.64e-05	4.98e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	1.63e-05	4.93e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	1.62e-05	4.9e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	1.6e-05	4.84e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	1.59e-05	4.8e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	1.54e-05	4.66e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	1.54e-05	4.65e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	1.51e-05	4.56e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	1.49e-05	4.52e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—coronary artery disease	1.41e-05	4.28e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	1.38e-05	4.19e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	1.31e-05	3.96e-05	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—AKT1—coronary artery disease	1.3e-05	3.95e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	1.29e-05	3.91e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	1.27e-05	3.84e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	1.24e-05	3.77e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—coronary artery disease	1.16e-05	3.51e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	1.08e-05	3.27e-05	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	1.07e-05	3.24e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—AKT1—coronary artery disease	1.05e-05	3.19e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	9.56e-06	2.89e-05	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	8.82e-06	2.67e-05	CbGpPWpGaD
